Drug Profile


Alternative Names: PAI-2; Plasminogen activator inhibitor (PAI) type 2

Latest Information Update: 19 Mar 2003

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Human Therapeutics; Network Limited
  • Developer Network Limited
  • Class Antineoplastics; Blood coagulation factors
  • Mechanism of Action Plasminogen activator inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Cancer; Psoriasis; Skin ulcer

Most Recent Events

  • 19 Mar 2003 No development reported - Phase-II for Psoriasis in Australia (Topical)
  • 19 Mar 2003 No development reported - Phase-II for Skin ulcer in Australia (Topical)
  • 30 Jun 2002 Biotech Australia has been acquired by, and merged into, GroPep
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top